Lucas W. Buchanan - 20 May 2022 Form 4 Insider Report for Silk Road Medical Inc

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
20 May 2022
Net transactions value
-$3,432,115
Form type
4
Filing time
12 Aug 2022, 20:45:36 UTC
Previous filing
04 Mar 2022
Next filing
17 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $33,961 +7,180 +2.9% $4.73 255,930 10 Aug 2022 Direct F1
transaction SILK Common Stock Sale $337,648 -7,180 -2.8% $47.03 248,750 10 Aug 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $34,105 +2,807 +1.1% $12.15 251,557 10 Aug 2022 Direct F1
transaction SILK Common Stock Sale $132,003 -2,807 -1.1% $47.03 248,750 10 Aug 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $12,128 +2,564 +1% $4.73 251,314 10 Aug 2022 Direct F1
transaction SILK Common Stock Sale $120,575 -2,564 -1% $47.03 248,750 10 Aug 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $59,693 +4,913 +2% $12.15 253,663 10 Aug 2022 Direct F1
transaction SILK Common Stock Sale $231,040 -4,913 -1.9% $47.03 248,750 10 Aug 2022 Direct F1, F2
transaction SILK Common Stock Award $13,480 +550 +0.22% $24.51 249,300 20 May 2022 Direct F3
transaction SILK Common Stock Sale $354,389 -7,536 -3% $47.03 241,764 10 Aug 2022 Direct F2, F4
transaction SILK Common Stock Sale $1,215,105 -25,000 -10% $48.60 216,764 11 Aug 2022 Direct F4, F5
transaction SILK Common Stock Sale $1,194,722 -25,000 -12% $47.79 191,764 12 Aug 2022 Direct F4, F6
holding SILK Common Stock 13,518 20 May 2022 Buchanan Grandchildren's Irrevocable Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -7,180 -100% $0.000000* 0 10 Aug 2022 Common Stock 7,180 $4.73 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -2,807 -100% $0.000000* 0 10 Aug 2022 Common Stock 2,807 $12.15 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -2,564 -100% $0.000000* 0 10 Aug 2022 Common Stock 2,564 $4.73 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -4,913 -100% $0.000000* 0 10 Aug 2022 Common Stock 4,913 $12.15 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
F2 This transaction was executed in multiple trades at price ranging from $46.15 to $48.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F4 The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
F5 This transaction was executed in multiple trades at price ranging from $47.38 to $49.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at price ranging from $47.29 to $48.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F8 All of the shares subject to this option are fully vested and exercisable as of the date hereof.